Citations

Citations to this article as recorded by  

• Influence of Lifestyles on Polyp Burden and Cancer Development in Hereditary Colorectal Cancer Syndromes
  Hye Kyung Hyun, Ji Soo Park, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
  Journal of Gastroenterology and Hepatology.2025; 40(2): 433.     CrossRef
• The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer
  Pengfei Zhang, Bing Pei, Chengxue Yi, Francis Atim Akanyibah, Fei Mao
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(2): 167578.     CrossRef
• Chronic Kidney Disease Increases Risk of Delayed Post‐Polypectomy Bleeding: A Large‐Scale Propensity Score‐Matched Analysis
  Hye Kyung Hyun, Nak‐Hoon Son, So Hyeon Gwon, Hyun Chul Lim, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Tae‐Hyun Yoo, Shin‐Wook Kang, Hae‐Ryong Yun, Cheal Wung Huh
  United European Gastroenterology Journal.2025;[Epub]     CrossRef
• An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update
  Susmita Roy, Dikshita Deka, Suresh Babu Kondaveeti, Pavithra Ayyadurai, Sravani Siripragada, Neha Philip, Surajit Pathak, Asim K. Duttaroy, Antara Banerjee
  Epigenetics.2025;[Epub]     CrossRef
• Minimum Platelet Count Threshold for Safe Colonoscopic Polypectomy: A Large-Scale Propensity Scored-Matched Analysis
  Hye Kyung Hyun, Nak-Hoon Son, Cheal Wung Huh, Hyun Chul Lim, So Hyeon Gwon, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
  American Journal of Gastroenterology.2025;[Epub]     CrossRef
• Anthocyanins: From Natural Colorants to Potent Anticancer Agents
  Muhammad Maaz, Muhammad Tauseef Sultan, Ahmad Mujtaba Noman, Shehnshah Zafar, Naima Tariq, Muzzamal Hussain, Muhammad Imran, Ahmed Mujtaba, Tadesse Fenta Yehuala, Ehab M. Mostafa, Samy Selim, Soad K. Al Jaouni, Suliman A. Alsagaby, Waleed Al Abdulmonem
  Food Science & Nutrition.2025;[Epub]     CrossRef
• Hsa-miR-21-5p and Hsa-miR-145-5p Expression: From Normal Tissue to Malignant Changes—Context-Dependent Correlation with Estrogen- and Hypoxia–Vascularization-Related Pathways Genes: A Pilot Study
  Mateusz Górecki, Aleksandra Żbikowska, Małgorzata Tokłowicz, Stefan Sajdak, Monika Englert-Golon, Mirosław Andrusiewicz
  International Journal of Molecular Sciences.2025; 26(9): 4461.     CrossRef
• Epigenetically Regulating Non-coding RNAs in Colorectal Cancer: Promises and Potentials
  Zahra Taheri, Majid Zaki-Dizaji
  Middle East Journal of Digestive Diseases.2025; 17(1): 40.     CrossRef
• miR-3065-5p and miR-26a-5p as Clinical Biomarkers in Colorectal Cancer: A Translational Study
  Berenice Carbajal-López, Antonio Daniel Martínez-Gutierrez, Eduardo O. Madrigal-Santillán, Germán Calderillo-Ruiz, José Antonio Morales-González, Jossimar Coronel-Hernández, Joey Lockhart, Oliver Millan-Catalan, Monica G. Mendoza-Rodriguez, Leonardo S. Li
  Cancers.2024; 16(21): 3649.     CrossRef

Citations

Citations to this article as recorded by  

• Comments on Oral Sulfate Solution Is as Effective as Polyethylene Glycol with Ascorbic Acid in a Split Method for Bowel Preparation in Patients with Inactive Ulcerative Colitis: A Randomized, Multicenter, and Single-Blind Clinical Trial
  Ji Eun Kim
  Gut and Liver.2024; 18(1): 192.     CrossRef
• Oral Sulfate Solution Is as Effective as Polyethylene Glycol with Ascorbic Acid in a Split Method for Bowel Preparation in Patients with Inactive Ulcerative Colitis: A Randomized, Multicenter, and Single-Blind Clinical Trial
  Ji Min Lee, Kang-Moon Lee, Ho Suk Kang, Ja Seol Koo, Hyun Seok Lee, Seok-Hoo Jeong, Jung Ho Kim, Dae Bum Kim
  Gut and Liver.2023; 17(4): 591.     CrossRef
• Quality indicators in colonoscopy: the chasm between ideal and reality
  Su Bee Park, Jae Myung Cha
  Clinical Endoscopy.2022; 55(3): 332.     CrossRef
• Comparison of the efficacy and safety between oral sulfate tablet and polyethylene glycol for bowel preparation before colonoscopy according to age
  Jae Hyun Kim, Yong Eun Park, Tae Oh Kim, Jongha Park, Gyu Man Oh, Won Moon, Seun Ja Park
  Medicine.2022; 101(27): e29884.     CrossRef
• Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study
  Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Eun Soo Kim, Yun Jin Chung, Byung Ik Jang, Sung Kook Kim, Chang Heon Yang
  Journal of Crohn's and Colitis.2022; 16(11): 1706.     CrossRef
• Comparison of Two Types of 1-L Polyethylene Glycol-ascorbic Acid as Colonoscopic Bowel Preparation: A Prospective Randomized Study
  Suh Hyun Choi, Won Eui Yoon, Seung Hyuk Kim, Hee Jun Myung, Seo Hyun Kim, Soon Oh So, Se Hun Kim, Hyun Mi Lee, Yeoun Jung Oh, Jeong Seop Moon, Tae Yeong Park, You Sun Kim
  The Korean Journal of Gastroenterology.2022; 80(2): 85.     CrossRef
• Correlation between Surrogate Quality Indicators for Adenoma Detection Rate and Adenoma Miss Rate in Qualified Colonoscopy, CORE Study: KASID Multicenter Study
  Jae Hee Han, Hyun Gun Kim, Eu Mi Ahn, Suyeon Park, Seong Ran Jeon, Jae Myung Cha, Min Seob Kwak, Yunho Jung, Jeong Eun Shin, Hyun Deok Shin, Young-Seok Cho
  Gut and Liver.2022; 16(5): 716.     CrossRef
• How to Choose the Optimal Bowel Preparation Regimen for Colonoscopy
  Ji Eun Na, Eun Ran Kim
  The Ewha Medical Journal.2021; 44(4): 122.     CrossRef
• Optimal Laxatives for Oral Colonoscopy Bowel Preparation: from High-volume to Novel Low-volume Solutions
  Soo-Young Na, Won Moon
  The Korean Journal of Gastroenterology.2020; 75(2): 65.     CrossRef
• No inferioridad entre dos agentes de bajo volumen (Picosulfato de Sodio/Citrato de Magnesio vs. Sulfato de Sodio/Potasio/Magnesio) en la preparación de colon para procedimientos diagnósticos: estudio observacional
  Erika D. Pérez-Riveros, Margarita Rey R., Belén Mendoza De Molano, Juan Carlos Robayo, Jaime Solano Mariño, Rafael García Duperly, Andrés Gómez, Renzo Pinto Carta, Gerardo Ardila, Jose De la Hoz-Valle, Fernando Sierra-Arango
  Revista Colombiana de Gastroenterología.2020; 35(4): 436.     CrossRef

Citations

Citations to this article as recorded by  

• Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
  Soo-Kyung Park, Sang-Bum Kang, SangSoo Kim, Tae Oh Kim, Jae Myung Cha, Jong Pil Im, Chang Hwan Choi, Eun Soo Kim, Geom Seog Seo, Chang Soo Eun, Dong Soo Han, Dong Il Park
  The Korean Journal of Internal Medicine.2022; 37(5): 949.     CrossRef

Approximately one-third of patients with Crohn's disease do not respond to conventional treatments, and some experience significant adverse effects, such as serious infections and lymphoma, and many patients require surgery due to complications. Increasing evidence suggests that specific changes in the composition of gut microbiota, termed as dysbiosis, are a common feature in patients with inflammatory bowel disease (IBD). Dysbiosis can lead to activation of the mucosal immune system, resulting in chronic inflammation and the development of mucosal lesions. Recently, fecal microbiota transplantation, aimed at modifying the composition of gut microbiota to overcome dysbiosis, has become a potential alternative therapeutic option for IBD. Herein, we present a patient with Crohn's colitis in whom biologic therapy failed previously, but clinical remission and endoscopic improvement was achieved after a single fecal microbiota transplantation infusion.

Citations

Citations to this article as recorded by  

• Role and mechanism of gut microbiota-host interactions in the pathogenesis of Crohn’s disease
  Yao Xu, Runxiang Xie, Yuqing Weng, Yewei Fang, Shuan Tao, He Zhang, Huimin Chen, Axiang Han, Qi Jiang, Wei Liang
  International Journal of Colorectal Disease.2025;[Epub]     CrossRef
• Epigenetics and the role of nutraceuticals in health and disease
  Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
  Environmental Science and Pollution Research.2023; 30(11): 28480.     CrossRef
• Crohn’s disease: Etiology, pathogenesis and treatment strategies
  Izel Aycan BASOGLU, Berna KARAKOYUN
  Marmara Medical Journal.2023; 36(2): 249.     CrossRef
• Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
  Eva Michaud, Louis Waeckel, Rémi Gayet, Roman Goguyer‐Deschaumes, Blandine Chanut, Fabienne Jospin, Katell Bathany, Magali Monnoye, Coraline Genet, Amelie Prier, Caroline Tokarski, Philippe Gérard, Xavier Roblin, Nicolas Rochereau, Stéphane Paul
  EMBO Molecular Medicine.2022;[Epub]     CrossRef
• Gut microbiota: A new target for T2DM prevention and treatment
  Lulu Liu, Jiheng Zhang, Yi Cheng, Meng Zhu, Zhifeng Xiao, Guangcong Ruan, Yanling Wei
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
  Cátia Almeida, Rita Oliveira, Pilar Baylina, Rúben Fernandes, Fábio G. Teixeira, Pedro Barata
  Biomedicines.2022; 10(11): 2742.     CrossRef
• Bibliometric and visual analysis of fecal microbiota transplantation research from 2012 to 2021
  Fengwei Zhang, Peilin Yang, Yilin Chen, Ruirui Wang, Baocheng Liu, Jianying Wang, Min Yuan, Lei Zhang
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis
  F. Cheng, Z. Huang, W. Wei, Z. Li
  Techniques in Coloproctology.2021; 25(5): 495.     CrossRef
• Management of Clostridioides difficile infection in patients with inflammatory bowel disease
  Sahil Khanna
  Intestinal Research.2021; 19(3): 265.     CrossRef
• Microbiota and epigenetics: promising therapeutic approaches?
  Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
  Environmental Science and Pollution Research.2021; 28(36): 49343.     CrossRef
• Improving the Gut Microbiota with Probiotics and Faecal Microbiota Transplantation
  Yogita M. Patil, Rajashree B. Patwardhan, Pragati S. Abhyankar
  Journal of Pure and Applied Microbiology.2021; 15(3): 1111.     CrossRef
• Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
  Yonghyun Lee, Nobuhiko Kamada, James J. Moon
  Advanced Drug Delivery Reviews.2021; 179: 114021.     CrossRef
• Alteration of Gut Microbiota in Autism Spectrum Disorder: An Overview
  Donghun Oh, Keun-Ah Cheon
  Journal of the Korean Academy of Child and Adolescent Psychiatry.2020; 31(3): 131.     CrossRef
• Development of the Korean Form of the Premonitory Urge for Tics Scale: A Reliability and Validity Study
  Mira Kim, Sang-Keun Chung, Jong-Chul Yang, Jong-Il Park, Seok Hyun Nam, Tae Won Park
  Journal of the Korean Academy of Child and Adolescent Psychiatry.2020; 31(3): 146.     CrossRef
• Secondary causes of inflammatory bowel diseases
  Yezaz A Ghouri, Veysel Tahan, Bo Shen
  World Journal of Gastroenterology.2020; 26(28): 3998.     CrossRef
• Fecal microbiota transplantation in the treatment of Crohn disease
  Miranda Collins, Morgan DeWitt
  JAAPA.2020; 33(9): 34.     CrossRef
• Inflammatory Bowel Diseases: The Role of Gut Microbiota
  Cristiana De Musis, Lucia Granata, Marcello Dallio, Agnese Miranda, Antonietta G. Gravina, Marco Romano
  Current Pharmaceutical Design.2020; 26(25): 2951.     CrossRef
• The human-microbiome superorganism and its modulation to restore health
  E. Salvucci
  International Journal of Food Sciences and Nutrition.2019; 70(7): 781.     CrossRef
• The microbiome, cancer, and cancer therapy
  Beth A. Helmink, M. A. Wadud Khan, Amanda Hermann, Vancheswaran Gopalakrishnan, Jennifer A. Wargo
  Nature Medicine.2019; 25(3): 377.     CrossRef
• RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
  Jung Hoon Song, You Sun Kim
  Gut and Liver.2019; 13(1): 16.     CrossRef
• Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
  Michael Kriss, Keith Z Hazleton, Nichole M Nusbacher, Casey G Martin, Catherine A Lozupone
  Current Opinion in Microbiology.2018; 44: 34.     CrossRef
• Microbiota transplantation: concept, methodology and strategy for its modernization
  Faming Zhang, Bota Cui, Xingxiang He, Yuqiang Nie, Kaichun Wu, Daiming Fan
  Protein & Cell.2018; 9(5): 462.     CrossRef
• The hygiene hypothesis at a glance: Early exposures, immune mechanism and novel therapies
  Gabriel M. Alexandre-Silva, Pablo A. Brito-Souza, Ana C.S. Oliveira, Felipe A. Cerni, Umberto Zottich, Manuela B. Pucca
  Acta Tropica.2018; 188: 16.     CrossRef
• The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study
  Honggang Wang, Bota Cui, Qianqian Li, Xiao Ding, Pan Li, Ting Zhang, Xiaozhong Yang, Guozhong Ji, Faming Zhang
  Advances in Therapy.2018; 35(11): 1935.     CrossRef
• Is there a potential role of fecal microbiota transplantation in the treatment of inflammatory bowel disease?
  Chang Soo Eun
  Intestinal Research.2017; 15(2): 145.     CrossRef
• Diagnosis and treatment of Crohn's disease
  Hyun-Soo Kim
  Journal of the Korean Medical Association.2017; 60(6): 484.     CrossRef